Retail investor sentiment around Hims & Hers Health remained negative over the weekend after the telehealth firm confirmed it ...

Dr Reddy's Laboratories had received the manufacturing licence for semaglutide in December 2024 and it began production in ...

Shares of firms like IndiGo, Tata Motors, BPCL, Vodafone Idea, BPCL, Nykaa, and others will be in focus on Monday's trade ...

Novo Nordisk’s semaglutide product to lose patent protection in China next year, according to L.E.K. Consulting.

Dozens of Aussie weight loss drug injection patients have complained of symptoms consistent with drug-induced hepatitis, ...

The global weight-loss drug market is experiencing exceptional growth, projected to expand from around $144.6 billion in 2023 ...

More than half a million Brits are thought to be now relying on weight loss drugs like Ozempic and Mounjaro, amid a steady ...

Legal battle over Novo Nordisk's semaglutide drug in India, with DRL, raises concerns over patent infringement and drug ...